EVMN Earnings Evommune, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–6 of 6
| Q1 2026 | 2026-03-31 | -0.64 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -11.22 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -26.36 | 2025-12-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -9.48 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -45.29 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -30.69 | 2025-12-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.